Statistics for Repro-Med Systems (id:5492 KRMD)
Valuation metrics
Market cap
167.08M
Enterprise value
134.74M
Trailing P/E (ttm)
-13.40
Forward P/E
-40.50
PEG ratio
-40.50
Price/Sales (ttm)
5.42
Price/Book (mrq)
8.17
Enterprise Value/Revenue
4.37
Enterprise Value/EBITDA
-21.56
Overview
Shares outstanding
45.84M
Float
33.47M
Shares short
486.92K
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
88.08K
Average volume (90 days)
Price summary
52-Week low
1.98
52-Week high
4.60
52-Week change
39.55%
Beta
3.00
50-Day moving average
3.24
200-Day moving average
2.58
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-38.16%
Operating margin
-14.14%
Operational effectiveness
Return on assets
-14.10%
Return on equity
-50.25%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
16.71M
EBITDA
-6,248,388.00
Net income to common (ttm)
-11,758,964.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
16.80%
Balance sheet
Total cash (mrq)
10.46M
Total cash per share (mrq)
3.00
Total debt (mrq)
3.97M
Total Debt/Equity (mrq)
21.21
Current ratio (mrq)
377.00%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-413,418.00
Levered free cash flow (LFCF)
1.05M